Literature DB >> 10602343

Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine.

S Y Yeung1, J A Millar, A Mathie.   

Abstract

1. The effect of the antidepressant drug, fluoxetine on neuronal delayed rectifier (KV) potassium (K) currents was investigated using perforated-patch whole-cell electrophysiological recording methods. 2. Fluoxetine was an effective inhibitor of KV currents in cerebellar granule neurons (CGNs) and also inhibited recombinant KV1.1 channels expressed in Chinese hamster ovary (CHO) cells. 3. Fluoxetine had an IC50 of 11 microM in CGNs but was slightly less potent on KV1.1 channels (IC50=55 microM). Interestingly, fluoxetine was a much more potent inhibitor of KV1.1 expressed in mammalian cells than has been found previously for the same homomeric channel expressed in Xenopus oocytes. 4. At concentrations that produced around 50% block, the shape of the KV currents in the presence of fluoxetine was simply scaled down when compared to control currents. 5. The effect of fluoxetine on KV currents in CGNs was neither voltage-dependent nor dependent on the channels being in their open state. Both of these observations suggest that fluoxetine does not act as a simple open channel blocking agent. 6. It is concluded that block of KV currents in mammalian neurons can occur at therapeutic levels of fluoxetine. This could lead to an increase in neuronal excitability and this effect may contribute to the therapeutic antidepressant action of fluoxetine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602343      PMCID: PMC1571791          DOI: 10.1038/sj.bjp.0702955

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Single-channel and whole-cell currents in rat cerebellar granule cells.

Authors:  T Jalonen; S Johansson; I Holopainen; S S Oja; P Arhem
Journal:  Brain Res       Date:  1990-12-03       Impact factor: 3.252

2.  Modifications of A-current kinetics in mammalian central neurones induced by extracellular zinc.

Authors:  R Bardoni; O Belluzzi
Journal:  J Physiol       Date:  1994-09-15       Impact factor: 5.182

3.  Immunohistochemical localization of five members of the Kv1 channel subunits: contrasting subcellular locations and neuron-specific co-localizations in rat brain.

Authors:  R W Veh; R Lichtinghagen; S Sewing; F Wunder; I M Grumbach; O Pongs
Journal:  Eur J Neurosci       Date:  1995-11-01       Impact factor: 3.386

4.  Modulation of the gating of the transient outward potassium current of rat isolated cerebellar granule neurons by lanthanum.

Authors:  C S Watkins; A Mathie
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

5.  Blockage of squid axon potassium conductance by internal tetra-N-alkylammonium ions of various sizes.

Authors:  R J French; J J Shoukimas
Journal:  Biophys J       Date:  1981-05       Impact factor: 4.033

6.  Inhibition by fluoxetine of voltage-activated ion channels in rat PC12 cells.

Authors:  S J Hahn; J S Choi; D J Rhie; C S Oh; Y H Jo; M S Kim
Journal:  Eur J Pharmacol       Date:  1999-02-12       Impact factor: 4.432

7.  Blockade of delayed rectifier K+ currents in neuroblastoma x glioma hybrid (NG 108-15) cells by clofilium, a class III antidysrhythmic agent.

Authors:  H L Reeve; C Peers
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

8.  Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1).

Authors:  J Tytgat; C Maertens; P Daenens
Journal:  Br J Pharmacol       Date:  1997-12       Impact factor: 8.739

9.  Heterogeneous Expression Patterns of Mammalian Potassium Channel Genes in Developing and Adult Rat Brain.

Authors:  Wilfried A. Kues; Frank Wunder
Journal:  Eur J Neurosci       Date:  1992       Impact factor: 3.386

10.  Human brain fluoxetine concentrations.

Authors:  C N Karson; J E Newton; R Livingston; J B Jolly; T B Cooper; J Sprigg; R A Komoroski
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1993       Impact factor: 2.198

View more
  17 in total

1.  The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity.

Authors:  Jianchao Xu; Peili Wang; Yanyan Li; Guoyong Li; Leonard K Kaczmarek; Yanling Wu; Pandelakis A Koni; Richard A Flavell; Gary V Desir
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

2.  Effects of dapoxetine on cloned Kv1.5 channels expressed in CHO cells.

Authors:  Imju Jeong; Shin Hee Yoon; Sang June Hahn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-04-27       Impact factor: 3.000

3.  Selective serotonin reuptake inhibitors facilitate ANO6 (TMEM16F) current activation and phosphatidylserine exposure.

Authors:  Hyun Jong Kim; Ikhyun Jun; Jae Seok Yoon; Jinsei Jung; Yung Kyu Kim; Woo Kyung Kim; Byung Joo Kim; Jaewoo Song; Sung Joon Kim; Joo Hyun Nam; Min Goo Lee
Journal:  Pflugers Arch       Date:  2015-01-30       Impact factor: 3.657

4.  Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).

Authors:  Toru Kobayashi; Kazuo Washiyama; Kazutaka Ikeda
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

5.  Reciprocal regulation of TREK-1 channels by arachidonic acid and CRH in mouse corticotropes.

Authors:  Andy K Lee; James L Smart; Marcelo Rubinstein; Malcolm J Low; Amy Tse
Journal:  Endocrinology       Date:  2011-02-22       Impact factor: 4.736

Review 6.  Variants in Ion Channel Genes Link Phenotypic Features of Bipolar Illness to Specific Neurobiological Process Domains.

Authors:  Yokesh Balaraman; Debomoy K Lahiri; John I Nurnberger
Journal:  Mol Neuropsychiatry       Date:  2015-02-20

7.  Interaction of paroxetine with mitochondrial proteins mediates neuroprotection.

Authors:  Joseph P Steiner; Muznabanu Bachani; Brett Wolfson-Stofko; Myoung-Hwa Lee; Tongguang Wang; Tonguang Wang; Guanhan Li; Wenxue Li; David Strayer; Norman J Haughey; Avindra Nath
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

Review 8.  Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?

Authors:  L Cardamone; M R Salzberg; T J O'Brien; N C Jones
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

9.  Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine.

Authors:  Louise E Kennard; Justin R Chumbley; Kishani M Ranatunga; Stephanie J Armstrong; Emma L Veale; Alistair Mathie
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

10.  Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus.

Authors:  Cassidy Delaney; Jason Gien; Theresa R Grover; Gates Roe; Steven H Abman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-09       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.